Prospects of Using of κ-Opioid Receptor Agonists U-50,488 and ICI 199,441 for Improving Heart Resistance to Ischemia/Reperfusion

Bull Exp Biol Med. 2015 Oct;159(6):718-21. doi: 10.1007/s10517-015-3057-8. Epub 2015 Oct 31.

Abstract

We studied the ability of the agonist of κ1-opioid receptors U-50,488 in doses of 0.1 and 1 mg/kg to simulate ischemic pre- and postconditioning of the heart and κ-opioid receptors ICI 199,441 in a dose of 0.1 mg/kg to simulate the antiarrhythmic effect of heart preconditioning. The duration of ischemia was 10 or 45 min and the duration of reperfusion was 10 min or 2 h. Administration of 1 mg/kg U-50,488 both before ischemia and 5 min before reperfusion produced a pronounced antiarrhythmic effect. U-50,488 injected 5 min before reperfusion 2-fold reduced the ratio of infarction to risk area. Administration of ICI 199,441 in a dose of 0.1 mg/kg 15 min before ischemia produced a potent antiarrhythmic effect. Antiarrhythmic effect of κ-opioid receptor agonists depended on activation of κ-opioid receptors.

Keywords: heart; postconditioning; reperfusion; κ-opioid receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology*
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / therapeutic use
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use
  • Cardiotonic Agents / pharmacology*
  • Cardiotonic Agents / therapeutic use
  • Ischemic Preconditioning, Myocardial / methods*
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / pathology
  • Myocardial Reperfusion Injury / prevention & control*
  • Pyrrolidines / pharmacology*
  • Pyrrolidines / therapeutic use
  • Rats
  • Rats, Wistar
  • Receptors, Opioid, kappa / agonists*

Substances

  • Anti-Arrhythmia Agents
  • Cardiotonic Agents
  • Pyrrolidines
  • Receptors, Opioid, kappa
  • kappa(1) opioid receptor
  • ICI 199441
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer